Cargando…
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions
Programmed cell death protein 1 (PD-1) is a critical inhibitory receptor that limits excessive T cell responses. Cancer cells have evolved to evade these immunoregulatory mechanisms by upregulating PD-1 ligands and preventing T cell–mediated anti-tumor responses. Consequently, therapeutic blockade o...
Autores principales: | Tocheva, Anna S., Peled, Michael, Strazza, Marianne, Adam, Kieran R., Lerrer, Shalom, Nayak, Shruti, Azoulay-Alfaguter, Inbar, Foster, Connor J.R., Philips, Elliot A., Neel, Benjamin G., Ueberheide, Beatrix, Mor, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939457/ https://www.ncbi.nlm.nih.gov/pubmed/33077516 http://dx.doi.org/10.1074/jbc.RA120.014745 |
Ejemplares similares
-
Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells
por: Strazza, Marianne, et al.
Publicado: (2021) -
Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth
por: Strazza, Marianne, et al.
Publicado: (2022) -
PD-1-stimulated T cell subsets are transcriptionally and functionally distinct
por: Lerrer, Shalom, et al.
Publicado: (2021) -
SLAMF6 clustering is required to augment T cell activation
por: Dragovich, Matthew A., et al.
Publicado: (2019) -
Immune checkpoint inhibitors and the shared epitope theory: from hypothesis to practice
por: Lerrer, Shalom, et al.
Publicado: (2019)